S.R. Park

Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer

D-Y. Oh, S-A Im, S.R. Park et al. · British Journal of Cancer · 2009 · 138 citations · Full text

Medicine, Oncology, Pharmacology +17

Sorafenib in patients with metastatic gastrointestinal stromal tumors who failed two or more prior tyrosine kinase inhibitors: a phase II study of Korean gastrointestinal stromal tumors study group

Se Hoon Park, Min‐Hee Ryu, Baek‐Yeol Ryoo et al. · Investigational New Drugs · 2012 · 115 citations

Medicine, Oncology, Pharmacotherapy +17

Comparison of surgical performance and short-term clinical outcomes between laparoscopic and robotic surgery in distal gastric cancer

Bang Wool Eom, Hong Man Yoon, Keun Won Ryu et al. · European Journal of Surgical Oncology · 2011 · 103 citations

Medicine, Oncology, Surgery +17

CYP2A6 and ERCC1 polymorphisms correlate with efficacy of S-1 plus cisplatin in metastatic gastric cancer patients

S.R. Park, S-Y Kong, B-H Nam et al. · British Journal of Cancer · 2011 · 55 citations · Full text

Medicine, Oncology, Pharmacology +16

Phase I/II study of S-1 combined with weekly docetaxel in patients with metastatic gastric carcinoma

S.R. Park, H. K. Kim, C. G. Kim et al. · British Journal of Cancer · 2008 · 22 citations · Full text

Medicine, Oncology, Pharmacology +17